NNOX
Nano-X Imaging Ltd.NASDAQHealthcare$2.41+0.00%ClosedMarket Cap: $153.7M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.97
P/S
12.28
EV/EBITDA
-2.54
DCF Value
$-0.83
FCF Yield
-30.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
-98.8%
Operating Margin
-469.7%
Net Margin
-452.8%
ROE
-32.5%
ROA
-31.6%
ROIC
-34.3%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 2025 | $3.4M | -86.4% | $-14.2M | $-13.7M | $-0.21 | — |
| Q2 2025 | $3.0M | -106.6% | $-14.5M | $-14.7M | $-0.23 | — |
| Q1 2025 | $2.8M | -108.3% | $-14.1M | $-13.2M | $-0.21 | — |
| Q4 2024 | $3.0M | -96.3% | $-15.0M | $-14.1M | $-0.23 | — |
| FY 2024 | $11.3M | -94.0% | $-56.7M | $-53.5M | $-0.91 | — |
| Q3 2024 | $3.0M | -92.8% | $-14.1M | $-13.6M | $-0.23 | — |
| Q2 2024 | $2.7M | -105.7% | $-14.5M | $-13.6M | $-0.23 | — |
| Q1 2024 | $2.6M | -84.3% | $-13.1M | $-12.2M | $-0.21 | — |
| Q4 2023 | $2.4M | -71.6% | $-13.3M | $-10.2M | $-0.18 | — |
| FY 2023 | $9.9M | -66.6% | $-62.6M | $-60.8M | $-1.08 | — |
| Q3 2023 | $2.5M | -67.0% | $-22.0M | $-21.4M | $-0.37 | — |
| Q2 2023 | $2.6M | -65.5% | $-17.8M | $-17.4M | $-0.31 | — |